Arsenic sulfide combined with JQ1, chemotherapy agents, or celecoxib inhibit gastric and colon cancer cell growth.
作者： Siyu Chen , Lian Zhang , Yingying Tong , Xiuli Zhang , Minggui Pan
DOI: 10.2147/DDDT.S92943
关键词:
摘要: Background Arsenic compounds have modest cytotoxic activity in solid tumors. We investigated if arsenic sulfide (As4S4) combination with other distinct agents could enhance its activity.
doaj.org参考文章(42)
Jae-Seok Roe, Fatih Mercan, Keith Rivera, Darryl J. Pappin, Christopher R. Vakoc, BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia Molecular Cell. ,vol. 58, pp. 1028- 1039 ,(2015) , 10.1016/J.MOLCEL.2015.04.011
A. Agrawal, I. S. Fentiman, NSAIDs and breast cancer: a possible prevention and treatment strategy. International Journal of Clinical Practice. ,vol. 62, pp. 444- 449 ,(2008) , 10.1111/J.1742-1241.2007.01668.X
Haifeng Qiu, Amanda L. Jackson, Joshua E. Kilgore, Yan Zhong, Leo Li-Ying Chan, Paola A. Gehrig, Chunxiao Zhou, Victoria L. Bae-Jump, JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer Oncotarget. ,vol. 6, pp. 6915- 6930 ,(2015) , 10.18632/ONCOTARGET.3126
Jeffrey G Supko, Rocio Garcia-Carbonero, Current Perspectives on the Clinical Experience, Pharmacology, and Continued Development of the Camptothecins Clinical Cancer Research. ,vol. 8, pp. 641- 661 ,(2002)
Stacia Kargman, Kazy Hay, Geeta Lal, Elizabeth Kwong, Bruno Hancock, Mark Redston, Tak Mak, Colleen Ash, Steven Gallinger, Jilly F. Evans, Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor. Cancer Research. ,vol. 61, pp. 6131- 6136 ,(2001)
HONGTAO WANG, FEI KE, JIE ZHENG, Hedgehog‑glioma‑associated oncogene homolog‑1 signaling in colon cancer cells and its role in the celecoxib‑mediated anti‑cancer effect Oncology Letters. ,vol. 8, pp. 2203- 2208 ,(2014) , 10.3892/OL.2014.2439
Carrie Printz, Celecoxib may prevent lung cancer. Cancer. ,vol. 118, pp. 3- 3 ,(2012) , 10.1002/CNCR.27371
Monica M. Bertagnolli, Craig J. Eagle, Ann G. Zauber, Mark Redston, Scott D. Solomon, KyungMann Kim, Jie Tang, Rebecca B. Rosenstein, Janet Wittes, Donald Corle, Timothy M. Hess, G. Mabel Woloj, Frédéric Boisserie, William F. Anderson, Jaye L. Viner, Donya Bagheri, John Burn, Daniel C. Chung, Thomas Dewar, T. Raymond Foley, Neville Hoffman, Finlay Macrae, Ronald E. Pruitt, John R. Saltzman, Bruce Salzberg, Thomas Sylwestrowicz, Gary B. Gordon, Ernest T. Hawk, Celecoxib for the Prevention of Sporadic Colorectal Adenomas The New England Journal of Medicine. ,vol. 355, pp. 873- 884 ,(2006) , 10.1056/NEJMOA061355
ZHENGGUANG LI, CHANGPING WU, JUN WU, MEI JI, LIANGRONG SHI, JINGTING JIANG, BIN XU, JINJIN YUAN, Synergistic antitumor effects of combined deguelin and cisplatin treatment in gastric cancer cells Oncology Letters. ,vol. 8, pp. 1603- 1607 ,(2014) , 10.3892/OL.2014.2368
J.-H. Mao, X.-Y. Sun, J.-X. Liu, Q.-Y. Zhang, P. Liu, Q.-H. Huang, K. K. Li, Q. Chen, Z. Chen, S.-J. Chen, As4S4 targets RING-type E3 ligase c-CBL to induce degradation of BCR-ABL in chronic myelogenous leukemia Proceedings of the National Academy of Sciences of the United States of America. ,vol. 107, pp. 21683- 21688 ,(2010) , 10.1073/PNAS.1016311108